samedan logo
home > pmps > summer 2007 > achieving equilibrium
Pharmaceutical Manufacturing and Packing Sourcer

Achieving Equilibrium

Erich R Brocker at SWISS CAPS AG examines the humidity balance in soft capsules and their potential future technological advances

Water is a key factor influencing the chemical and microbial stability of packaged nutritional and pharmaceutical products. Product development and design often goes along with the manufacturing process, from active pharmaceutical ingredients (APIs) to formulation and from bulk manufacturing to packaging.

Soft capsules (SC) are a solid dosage form, invented about 70 years ago, widely used in the pharmaceutical, nutritional and cosmetic industries. The term ‘soft’ refers to plasticisers in the capsule shell, which make it flexible and less brittle. As the capsule is filled with liquid or pasty fill formulations, it is sometimes also called a semi-solid dosage form. SCs are well established in consumer perception, largely due to the following advantages:

  • Elegant appearance
  • Easy to swallow
  • Very good consumer confidence
  • Rapid action (dispersing capsule contents)
  • Improved bioavailability
  • Good tolerance to intestinal mucosa
  • Masks odours

Some years ago the purely vegetable-based soft capsule was manufactured by a revolutionary combination of extrusion technology and the reliable rotary-die process. This allowed for low-water shells. This breakthrough opened enormous opportunities for new formulations of existing and future products, ideally leading to an increased popularity of soft capsules, whilst addressing new and large consumer target groups.

In the past, only gelatin-water solutions could be used in the casting (or dropping) process to form a uniform shell around the fill. Throughout the shelf live period water is a major factor influencing the chemical stability of APIs, including vitamins, minerals and plant extracts. However, few publications exist which address the mechanisms of water migration between environment, soft capsule shell and its fill, influencing the stability of APIs. Special attention must be paid to an interaction of water with APIs if soft capsules with a ‘wet shell’ are used as a dosage form. After the encapsulation of fill, the soft gelatin capsules undergo a drying process to lose approximately 35 per cent of the water out of the shell. The final moisture content of a gelatin shell coming from production stays at around six to 10 per cent (aw=0.3) when delivered for packaging.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

Dr Erich R Brocker is Senior Manager New Technologies at SWISS CAPS AG in Kirchberg, Switzerland, an international full service manufacturer for the pharmaceutical, healthcare and cosmetic industry. He studied Chemistry at the ETH (Swiss Federal Institute of Technology) in Zurich and obtained his PhD from the Institute of Toxicology at the ETH and the University Zurich, Switzerland. From 1981-1982 he was a post-doctoral fellow at the University of Calgary, Canada. In 1982 he started to work with SWISS CAPS AG as Production Manager R&D for about nine years. For the following three years he was a Project Manager at Micarna AG in Bazenheid, Switzerland, a food manufacturing company. In 1994 he returned to SWISS CAPS AG in Kirchberg, where he started working as Head of R&D and QA, and was responsible for the development of the first gelatin-free soft capsules. He then undertook his current position as Senior Manager New Technologies.
Dr Erich R Brocker
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera and Noble announce collaboration to support patients who self-administer medication

Nemera is excited to leverage the new collaboration to expand end-to- end offering of the parenteral franchise and increase patient onboarding through safer multi-use training devices
More info >>

White Papers

What Your Clinical Study Design Reveals About Your Clinical Packaging Needs

PCI Pharma Services

As the cost and complexities of drug development increase, so do the challenges of global clinical trials. Today’s sponsors must be able to manage and coordinate multiple resources, processes, and locations with speed and accuracy to design effective and efficient clinical trials. Securing a stable supply chain to deal with the uncertainties of clinical trials is critical. One misstep can have a profound impact not only on the cost and time of your trial but also on its overall success.
More info >>

Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement